An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA–loaded dendritic cells for cancer vaccination.
Saved in:
| Title: | An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA–loaded dendritic cells for cancer vaccination. |
|---|---|
| Authors: | BRABANTS, E.1 Elisabeth.Brabants@ugent.be, HEYNS, K.1, SMET, S. DE2, DEVREKER, P.2, INGELS, J.2, CABOOTER, N. DE1,3, DEBACKER, V.1,3, DULLAERS, M.1,3, VAN MEERBEECK, J.P.4, VANDEKERCKHOVE, B.2, VERMAELEN, K.Y.1 |
| Source: | Cytotherapy (Elsevier Inc.). Sep2018, Vol. 20 Issue 9, p1164-1181. 18p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 132488756 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA–loaded dendritic cells for cancer vaccination. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22BRABANTS%2C+E%2E%22">BRABANTS, E.</searchLink><relatesTo>1</relatesTo><i> Elisabeth.Brabants@ugent.be</i><br /><searchLink fieldCode="AR" term="%22HEYNS%2C+K%2E%22">HEYNS, K.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22SMET%2C+S%2E+DE%22">SMET, S. DE</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22DEVREKER%2C+P%2E%22">DEVREKER, P.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22INGELS%2C+J%2E%22">INGELS, J.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22CABOOTER%2C+N%2E+DE%22">CABOOTER, N. DE</searchLink><relatesTo>1,3</relatesTo><br /><searchLink fieldCode="AR" term="%22DEBACKER%2C+V%2E%22">DEBACKER, V.</searchLink><relatesTo>1,3</relatesTo><br /><searchLink fieldCode="AR" term="%22DULLAERS%2C+M%2E%22">DULLAERS, M.</searchLink><relatesTo>1,3</relatesTo><br /><searchLink fieldCode="AR" term="%22VAN+MEERBEECK%2C+J%2EP%2E%22">VAN MEERBEECK, J.P.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22VANDEKERCKHOVE%2C+B%2E%22">VANDEKERCKHOVE, B.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22VERMAELEN%2C+K%2EY%2E%22">VERMAELEN, K.Y.</searchLink><relatesTo>1</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cytotherapy+%28Elsevier+Inc%2E%29%22">Cytotherapy (Elsevier Inc.)</searchLink>. Sep2018, Vol. 20 Issue 9, p1164-1181. 18p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=132488756 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jcyt.2018.06.006 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 18 StartPage: 1164 Titles: – TitleFull: An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA–loaded dendritic cells for cancer vaccination. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: BRABANTS, E. – PersonEntity: Name: NameFull: HEYNS, K. – PersonEntity: Name: NameFull: SMET, S. DE – PersonEntity: Name: NameFull: DEVREKER, P. – PersonEntity: Name: NameFull: INGELS, J. – PersonEntity: Name: NameFull: CABOOTER, N. DE – PersonEntity: Name: NameFull: DEBACKER, V. – PersonEntity: Name: NameFull: DULLAERS, M. – PersonEntity: Name: NameFull: VAN MEERBEECK, J.P. – PersonEntity: Name: NameFull: VANDEKERCKHOVE, B. – PersonEntity: Name: NameFull: VERMAELEN, K.Y. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: Sep2018 Type: published Y: 2018 Identifiers: – Type: issn-print Value: 14653249 Numbering: – Type: volume Value: 20 – Type: issue Value: 9 Titles: – TitleFull: Cytotherapy (Elsevier Inc.) Type: main |
| ResultId | 1 |